Cite
HARVARD Citation
Kinoshita, I. et al. (n.d.). 1491PA phase II study of trastuzumab monotherapy in pretreated patients with non-small cell lung cancers (NSCLCs) harboring HER2 alterations: HOT1303-B trial. Annals of oncology. p. . [Online].